Whole blood cardioplegia (minicardioplegia) reduces myocardial edema after ischemic injury and cardiopulmonary bypass
- PMID: 16637518
- PMCID: PMC4680760
Whole blood cardioplegia (minicardioplegia) reduces myocardial edema after ischemic injury and cardiopulmonary bypass
Abstract
While blood:crystalloid cardioplegia is the clinical standard for patients undergoing cardiopulmonary bypass (CPB), it has been postulated that whole blood minicardioplegia may benefit the severely injured heart by reducing cardioplegic volume, thereby reducing myocardial edema. To test this hypothesis, we compared the cardioprotection of a popular 4:1 blood:crystalloid cardioplegia to whole blood minicardioplegia (WB) in a porcine model of acute myocardial ischemia. Yorkshire pigs (n = 20) were placed on atriofemoral bypass and subjected to 30 minutes of global normothermic ischemia. Animals were randomized to receive either 4:1 cold cardioplegia (n = 10) or WB cold cardioplegia (n = 10) delivered antegrade continuously for 90 minutes. Baseline (BL) echocardiographic determination of left ventricular mass (LVM) was compared within groups for cardiac edema (%) measured by histologic morphometrics. All (100%) animals receiving WB were successfully weaned off CPB, whereas only 40% of animals receiving 4:1 were successfully weaned off CPB. Cardiac edema percentage (p < .004) and LVM (p < .05) were significantly decreased in the WB group compared with 4:1. WB cardioplegia increases the number of hearts successfully weaned from CPB and decreases cardiac edema in our porcine model of acute myocardial ischemia. This finding implies whole blood cardioplegia may be more protective in a select group of patients undergoing extended CPB time by decreasing myocardial edema.
Conflict of interest statement
The senior author has stated that authors have reported no material, financial or other relationship with any healthcare-related business or other entity whose products or services are discussed in this paper.
Figures






Similar articles
-
Warm blood cardioplegia: superior protection after acute myocardial ischemia.Ann Thorac Surg. 1993 Jan;55(1):32-41; discussion 41-2. doi: 10.1016/0003-4975(93)90470-3. Ann Thorac Surg. 1993. PMID: 8417708
-
Pyruvate-fortified cardioplegia evokes myocardial erythropoietin signaling in swine undergoing cardiopulmonary bypass.Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1914-22. doi: 10.1152/ajpheart.01213.2008. Epub 2009 Sep 18. Am J Physiol Heart Circ Physiol. 2009. PMID: 19767525 Free PMC article.
-
Orthotopic transplantation of pig hearts harvested after 30 min of normothermic ischemia: controlled reperfusion with blood cardioplegia containing the Na+-H+-exchange inhibitor HOE 642.Eur J Cardiothorac Surg. 1998 Dec;14(6):607-14. doi: 10.1016/s1010-7940(98)00236-x. Eur J Cardiothorac Surg. 1998. PMID: 9879873
-
Is blood cardioplegia superior to crystalloid cardioplegia?Interact Cardiovasc Thorac Surg. 2008 May;7(3):491-8. doi: 10.1510/icvts.2008.178343. Epub 2008 Mar 13. Interact Cardiovasc Thorac Surg. 2008. PMID: 18339688 Review.
-
Myocardial protection in cardiac surgery: how limited are the options? A comprehensive literature review.Perfusion. 2021 May;36(4):338-351. doi: 10.1177/0267659120942656. Epub 2020 Jul 31. Perfusion. 2021. PMID: 32736492 Review.
Cited by
-
Re-dosing of del Nido cardioplegia in adult cardiac surgery requiring prolonged aortic cross-clamp.Interact Cardiovasc Thorac Surg. 2022 Mar 31;34(4):556-563. doi: 10.1093/icvts/ivab310. Interact Cardiovasc Thorac Surg. 2022. PMID: 34788429 Free PMC article.
-
Does the Type of Cardioplegic Technique Influence Hemodilution and Transfusion Requirements in Adult Patients Undergoing Cardiac Surgery?J Extra Corpor Technol. 2017 Dec;49(4):231-240. J Extra Corpor Technol. 2017. PMID: 29302113 Free PMC article.
-
Is crystalloid cardioplegia a strong predictor of intra-operative hemodilution?J Cardiothorac Surg. 2014 Jan 27;9:23. doi: 10.1186/1749-8090-9-23. J Cardiothorac Surg. 2014. PMID: 24468006 Free PMC article. Clinical Trial.
-
Del Nido Cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: a propensity matched comparison.J Cardiothorac Surg. 2014 Oct 30;9:141. doi: 10.1186/s13019-014-0141-5. J Cardiothorac Surg. 2014. PMID: 25359427 Free PMC article.
-
Whole Blood Cardioplegia: Do We Still Need to Dilute?J Extra Corpor Technol. 2016 Jun;48(2):P9-P14. J Extra Corpor Technol. 2016. PMID: 27578906 Free PMC article. No abstract available.
References
-
- Cohen G, Borger MA, Weisel RD, et al. . Intraoperative myocardial protection: current trends and future perspectives. Ann Thorac Surg. 1999;68:1995–2001. - PubMed
-
- Christakis GT, Ivanov J, Weisel RD, et al. . The changing pattern of coronary artery bypass surgery. Circulation. 1989;80(suppl I):I-151–61. - PubMed
-
- Menasché P.. Blood cardioplegia: do we still need to dilute? Ann Thorac Surg. 1996;62:957–60. - PubMed
-
- Menasché P, Touchot B, Pradier F, et al. . Simplified method for delivering normothermic blood cardioplegia. Ann Thorac Surg. 1993;55:177–8. - PubMed
-
- Laine GA, Allen SJ.. Left ventricular myocardial edema: lymph flow, interstitial fibrosis, and cardiac function. Circ Res. 1991;68:1713–21. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical